S W Andrews
Overview
Explore the profile of S W Andrews including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
453
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Andrews S, Kabrah S, May J, Donaldson C, Morse H
Br J Biomed Sci
. 2013 Nov;
70(3):110-20.
PMID: 24273897
Multiple myeloma is the most common haematological malignancy yet currently it remains incurable. For decades the mainstay in therapy has been non-targeted approaches including genotoxic agents and immunosuppressants. With myeloma...
2.
Vaishnavi A, Capelletti M, Le A, Kako S, Butaney M, Ercan D, et al.
Nat Med
. 2013 Oct;
19(11):1469-1472.
PMID: 24162815
We identified new gene fusions in patients with lung cancer harboring the kinase domain of the NTRK1 gene that encodes the high-affinity nerve growth factor receptor (TRKA protein). Both the...
3.
Woodward D, Krauss A, Chen J, Liang Y, Li C, Protzman C, et al.
J Pharmacol Exp Ther
. 2003 Feb;
305(2):772-85.
PMID: 12606640
Replacement of the carboxylic acid group of prostaglandin (PG) F(2alpha) with a nonacidic moiety, such as hydroxyl, methoxy, or amido, results in compounds with unique pharmacology. Bimatoprost (AGN 192024) is...
4.
Woodward D, Krauss A, Chen J, Lai R, Spada C, Burk R, et al.
Surv Ophthalmol
. 2001 Jul;
45 Suppl 4:S337-45.
PMID: 11434936
Bimatoprost (Lumigan) is a pharmacologically unique and highly efficacious ocular hypotensive agent. It appears to mimic the activity of a newly discovered family of fatty acid amides, termed prostamides. One...
5.
Schuster V, Itoh S, Andrews S, Burk R, Chen J, Kedzie K, et al.
Mol Pharmacol
. 2000 Nov;
58(6):1511-6.
PMID: 11093791
Several principles governing the binding of E series prostaglandins to EP receptors have emerged in recent years. The C-1 carboxyl group binds electrostatically to a conserved arginine residue in the...
6.
Woodward D, Krauss A, Chen J, Gil D, Kedzie K, Protzman C, et al.
Br J Pharmacol
. 2000 Aug;
130(8):1933-43.
PMID: 10952685
Replacement of the carboxylic acid group of PGF(2alpha) with the non-acidic substituents hydroxyl (-OH) or methoxy (-OCH(3)) resulted in an unexpected activity profile. Although PGF(2alpha) 1-OH and PGF(2alpha) 1-OCH(3) exhibited...
7.
Woodward D, Bogardus A, Donello J, Fairbairn C, Gil D, Kedzie K, et al.
J Ocul Pharmacol Ther
. 1995 Jan;
11(3):447-54.
PMID: 8590276
The cloning of the genes that encode for prostaglandin (PG) receptors has resolved much of the complexity and controversy in this area by confirming the classification proposed by Coleman, et...
8.
Hillman J, Andrews S, Dzuback A
Infect Immun
. 1987 Jun;
55(6):1399-402.
PMID: 3570471
Eleven different laboratory strains of Streptococcus mutans representing the various serogroups were found to produce an average of 6.0 +/- 4.8 mM acetoin when grown in glucose-containing medium under aerobic...
9.
Hillman J, Dzuback A, Andrews S
J Dent Res
. 1987 Jun;
66(6):1092-4.
PMID: 3476580
Streptococcus mutans strain JH1005 is a mutant that produces levels of bacteriocin activity three-fold-elevated than those produced by its parent, JH1001. A single infection regimen with JH1005 was found to...
10.